CONSULTING AGREEMENTConsulting Agreement • May 9th, 2024 • Viracta Therapeutics, Inc. • Pharmaceutical preparations
This consulting agreement ("Agreement") is made by and between Viracta Therapeutics, Inc., having a place of business at 2533 South Coast Hwy 101, Suite 210, Cardiff, CA 92007 USA, together with its affiliates ("Company") and Daniel Chevallard, an individual with a place of business at [***] ("Consultant"), effective as of March 20, 2024 (one minute before the effective time of Consultant’s resignation from his former position as Chief Financial Officer and Chief Operating Officer of the Company) for the purpose of setting forth the exclusive terms and conditions by which Company will acquire Consultant’s services on a temporary basis.
